miR-135b seems to play a role in controlling the EMT in ovarian cancer by regulating p-Akt and PTEN expression levels, resulting in the alteration of EMT-associated proteins such as E-cadherin, N-cadherin, Snail and vimentin [59]. This evidence concerns the gene CDH1 and ovarian carcinoma.